Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesNeurology/NeurosurgeryHighmark Pennsylvania EMG Coverage Policy Update |…
    Ask Trek AI about this page
    CurrentHighmark PennsylvaniaPolicy M-28-030

    Electromyography (EMG)

    Customize your policy alerts

    Sign up for Highmark Pennsylvania Policy M-28-030 alerts

    Get alerted when Policy M-28-030 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage limitations, and billing guidance for electromyography (EMG) studies for Highmark Pennsylvania commercial lines of business.

    Policy Summary
    PayerHighmark Pennsylvania
    PolicyElectromyography (EMG)
    Policy CodePolicy M-28-030
    Change TypeNo material change
    Effective DateSep 26, 2016
    Last ReviewMar 20, 2016
    Next Review Date
    Key ActionApply the policy on a pre-payment basis for professional and facility claims; note specified post-payment diagnosis code applications.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Any one of 7covered clinical indications listed
    1H-reflex studies limited per session per code
    2

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    repetitive stimulation studies limited per session
    surface & macro EMGexperimental/investigational — not covered
    Outpatientplace of service

    Coverage Criteria — When EMG is Medically Necessary

    Medically Necessary Indications

    Electromyography (EMG) may be considered medically necessary for ANY ONE of the following:

    Covered indications: Nerve compression syndromes, including carpal tunnel syndrome and other focal compressions; Radiculopathy (cervical, lumbosacral); Mono/polyneuropathy (metabolic, degenerative, hereditary); Myopathy (including polymyositis, dermatomyositis, myotonic, and congenital myopathies); Plexopathy (idiopathic, trauma, infiltration); Neuromuscular junction disorders (i.e. myasthenia gravis); Botulinum toxin type A (BOTOX®) injection for localization or prior to injection of phenol or other substances for nerve blocking or chemodenervation.ANY 1

    EMG covered if any one condition applies

    Electromyography (EMG) for indications other than the conditions listed as medically necessary in this policy is not medically necessary and therefore non‑covered. The covered indications are limited to the specific clinical scenarios enumerated in the policy (e.g., nerve compression syndromes, radiculopathy, mono/polyneuropathy, myopathy, plexopathy, neuromuscular junction disorders, and localization prior to botulinum toxin or phenol injections). A “surface” EMG and macro EMG are specifically considered experimental/investigational and non‑covered because current scientific evidence does not support their use.

    Any EMG performed for an indication that is not among the listed covered conditions will be considered not medically necessary and will not be covered. In addition to being non‑covered, surface EMG and macro EMG are classified as experimental/investigational. Providers billing for experimental/investigational services must follow member financial consent requirements described elsewhere in the policy when applicable.

    Coding, Limits, and Billing Guidance

    H-reflex testingCPTCovered
    95907-95913H-reflex testing
    Procedures with post-payment diagnosis code applicationCPT
    92265Referenced procedure code requiring post-payment diagnosis code application
    95867Referenced procedure code requiring post-payment diagnosis code application
    95868Referenced procedure code requiring post-payment diagnosis code application
    95874Referenced procedure code requiring post-payment diagnosis code application
    inv-06: H-reflex studies per session — limited to one unilateral or bilateral study per session per code
    Limit per sessionPayment for H-reflex testing (CPT 95907-95913) is limited to one unilateral or bilateral study per session per code.
    Billing contextH-reflex testing may be paid separately from listed EMG and NCV studies.
    Place of service noteApplies to professional and facility claims (policy applied pre-payment); facility payments subject to retrospective review.
    inv-07: Repetitive stimulation tests per session — limited to two repetitive stimulations per session
    Limit per sessionNeuromuscular junction testing (repetitive stimulation) is limited to two repetitive stimulations per session.
    Processing

    Provider Responsibilities and Claims Handling

    Billing Rule

    Pre-payment application

    This policy is applied on a pre-payment basis for both professional and facility claims. Certain diagnosis-code applications and limits are applied post-payment as noted below.

    • Professional claims: policy applied on a pre-payment basis; diagnosis codes for 92265, 95867, 95868, 95874 reviewed post-payment.
    • Facility claims: policy applied on a pre-payment basis; diagnosis codes for 92265, 95867, 95868, 95874 reviewed post-payment.
    • H-reflex testing (95907-95913): limit to one unilateral or bilateral study per session per code.
    • Neuromuscular junction testing (repetitive stimulation): limit to two repetitive stimulations per session.
    • Services paid on initial processing may be subject to retrospective review.

    Background

    Electromyography (EMG) is the study and recording of the intrinsic electrical properties of skeletal muscle. EMG results reflect both the integrity of the functional connection between a nerve and its innervated muscle and the integrity of the muscle itself. EMG is used to evaluate conditions such as nerve compression syndromes (including carpal tunnel), radiculopathies, mono‑ or polyneuropathies, myopathies, plexopathies, and neuromuscular junction disorders, and to assist with localization prior to certain neurotoxin or chemodenervation procedures.

    Definitions and Testing Types

    inv-13: Surface EMG / Macro EMG — types considered experimental/investigational and non-covered
    Non-covered testsSurface EMG is considered experimental/investigational and is non-covered.
    Non-covered testsMacro EMG is considered experimental/investigational and is non-covered.
    RationaleScientific evidence does not support the use of surface EMG and macro EMG.
    inv-14: H-reflex testing — defined as separate test; may be paid in addition to listed EMG/NCV studies; limited to one unilateral or bilateral study per session per code
    DefinitionH-reflex testing is defined as a separate test that may be paid in addition to listed EMG and NCV studies.
    Limit per sessionPayment should be limited to one unilateral or bilateral study per session per code (CPT 95907-95913).
    Policy Summary
    PayerHighmark Pennsylvania
    PolicyElectromyography (EMG)
    Policy CodePolicy M-28-030
    Change TypeNo material change
    Effective DateSep 26, 2016
    Last ReviewMar 20, 2016
    Next Review Date
    Key ActionApply the policy on a pre-payment basis for professional and facility claims; note specified post-payment diagnosis code applications.
    SourceLink
    On This Page
    Coverage Criteria — When EMG is Medically NecessaryCoding, Limits, and Billing GuidanceProvider Responsibilities and Claims HandlingBackgroundDefinitions and Testing Types
    Repetitive stimulation tests should be processed separately from other EMG/NCV studies.
    Claim applicationPolicy applied on a pre-payment basis for professional and facility claims; specific procedure codes may have post-payment diagnosis applications.
    Denial Risk

    Denial triggers

    Services that do not meet the criteria of this policy will be denied as not medically necessary. Experimental/investigational (E/I) services are not covered. A network provider cannot bill the member for a denied service unless the provider has provided advance written notice, a cost estimate, and obtained the member's written agreement to assume financial responsibility in advance; the signed agreement must be maintained in the provider’s records.

    • Denied services: provider must give advance written notice, cost estimate, and obtain member's written agreement to bill for denied service; keep signed agreement in records.
    • Experimental/investigational services: not covered; provider must follow E/I consent rules (see below) if billing member.
    Documentation Required

    Member financial consent for E/I services

    If a provider intends to bill a member for an experimental/investigational (E/I) service, the provider must give advance written notice that the service has been deemed E/I, provide the member with an estimate of the cost, and obtain the member’s written agreement to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.

    • Applies when billing member for E/I services — advance written notice required.
    • Member must receive a cost estimate and provide written consent assuming financial responsibility.
    • Signed agreement must be retained in provider records.
    Note

    Providers should follow billing and coding limits specific to EMG/NCV services and referenced Medical Policy Bulletins. Surface EMG and macro EMG are considered experimental/investigational and non-covered. Refer to M-51 for NCV studies and M-13 for intraoperative neurophysiologic monitoring.

    • Surface EMG and macro EMG: non-covered (E/I).
    • Refer to M-51 for Nerve Conduction Velocity (NCV) studies.
    • Refer to M-13 for Intraoperative Neurophysiologic Monitoring guidance.
    Claims handlingPolicy is applied on a pre-payment basis for professional and facility claims; facility payments are subject to retrospective review.
    inv-15: Neuromuscular junction testing (repetitive stimulation) — testing for neuromuscular junction disorders; limited to two repetitive stimulations per session and processed separately
    PurposeNeuromuscular junction testing (repetitive stimulation) is used to evaluate neuromuscular junction disorders (e.g., myasthenia gravis).
    Limit per sessionTesting is limited to two repetitive stimulations per session and should be processed separately.
    Claims processingPolicy applied on a pre-payment basis for professional and facility claims; certain procedure codes require post-payment diagnosis code application.